Human Challenge Studies for Vaccine Development

This volume offers insights into human challenge studies, where adult volunteers are deliberately infected with a pathogen of interest. These studies can broaden our knowledge on infections that have a rather low natural infection rate, but still bear a great threat to global health. The authors als...

Full description

Saved in:
Bibliographic Details
Corporate Author: SpringerLink (Online service)
Other Authors: Bagnoli, Fabio (Editor), Del Giudice, Giuseppe (Editor), Phogat, Sanjay K. (Editor), Rappuoli, Rino (Editor)
Format: Electronic eBook
Language:English
Published: Cham : Springer Nature Switzerland : Imprint: Springer, 2024.
Edition:1st ed. 2024.
Series:Current Topics in Microbiology and Immunology, 445
Subjects:
Online Access:https://doi.org/10.1007/978-3-031-63118-4
Tags: Add Tag
No Tags, Be the first to tag this record!

MARC

LEADER 00000nam a22000005i 4500
001 978-3-031-63118-4
003 DE-He213
005 20251113174048.0
007 cr nn 008mamaa
008 241027s2024 sz | s |||| 0|eng d
020 |a 9783031631184  |9 978-3-031-63118-4 
024 7 |a 10.1007/978-3-031-63118-4  |2 doi 
050 4 |a QR180-189.5 
072 7 |a MJCM  |2 bicssc 
072 7 |a MED044000  |2 bisacsh 
072 7 |a MJCM  |2 thema 
082 0 4 |a 571.96  |2 23 
082 0 4 |a 616.079  |2 23 
245 1 0 |a Human Challenge Studies for Vaccine Development  |h [electronic resource] /  |c edited by Fabio Bagnoli, Giuseppe Del Giudice, Sanjay K. Phogat, Rino Rappuoli. 
250 |a 1st ed. 2024. 
264 1 |a Cham :  |b Springer Nature Switzerland :  |b Imprint: Springer,  |c 2024. 
300 |a VIII, 377 p. 40 illus., 25 illus. in color.  |b online resource. 
336 |a text  |b txt  |2 rdacontent 
337 |a computer  |b c  |2 rdamedia 
338 |a online resource  |b cr  |2 rdacarrier 
347 |a text file  |b PDF  |2 rda 
490 1 |a Current Topics in Microbiology and Immunology,  |x 2196-9965 ;  |v 445 
505 0 |a A brief history of human challenge studies (1900-2021) emphasising the virology, regulatory and ethical requirements, raison d’etre, ethnography, selection of volunteers and unit design -- Regulatory aspects of human challenge studies.-Controlled Human Infection challenge studies with RSV -- Human challenge studies with coronaviruses old and new -- Experimental urethral infection with Neisseria gonorrhoeae -- Helicobacter pylori.-Controlled human infection with Bordetella pertussis Human challenge studies for cholera -- The Controlled Human Infection Model for Enterotoxigenic Escherichia coli -- Challenges in developing a controlled human tuberculosis challenge model -- Shigella Controlled Human Infection Models: Current and Future Perspectives -- The background, role and outline approach for development of a Controlled Human Infection Model for Nontyphoidal Salmonella -- Controlled Human Malaria Infection studies in Africa - past, present, and future -- Controlled infection of humans with the hookworm parasite Necator americanus to accelerate vaccine development. 
520 |a This volume offers insights into human challenge studies, where adult volunteers are deliberately infected with a pathogen of interest. These studies can broaden our knowledge on infections that have a rather low natural infection rate, but still bear a great threat to global health. The authors also present instances, where no suitable animal model is available to help understand human immune responses to a specific pathogen. The recent SARS-CoV-2 pandemic is another example, where studies that are directly conducted in humans, could save valuable time. Human challenge studies can provide immunogenicity and early efficacy data for vaccine development. However, similar models could be used for studying a wide variety of medical treatments such as monoclonal antibodies, antibiotics, antivirals and bacteriophages. The chapters in this volume cover several pathogens, including viruses, bacteria and parasites, scientific and technical aspects as well as descriptions of regulatory, ethical and manufacturing requirements. The book serves as a valuable resource for scientists and clinicians working on human pathogens. 
650 0 |a Immunology. 
650 0 |a Medical microbiology. 
650 0 |a Medicine  |x Research. 
650 0 |a Biology  |x Research. 
650 0 |a Diseases  |x Causes and theories of causation. 
650 1 4 |a Immunology. 
650 2 4 |a Medical Microbiology. 
650 2 4 |a Translational Research. 
650 2 4 |a Pathogenesis. 
700 1 |a Bagnoli, Fabio.  |e editor.  |0 (orcid)0009-0001-3420-0452  |1 https://orcid.org/0009-0001-3420-0452  |4 edt  |4 http://id.loc.gov/vocabulary/relators/edt 
700 1 |a Del Giudice, Giuseppe.  |e editor.  |4 edt  |4 http://id.loc.gov/vocabulary/relators/edt 
700 1 |a Phogat, Sanjay K.  |e editor.  |4 edt  |4 http://id.loc.gov/vocabulary/relators/edt 
700 1 |a Rappuoli, Rino.  |e editor.  |0 (orcid)0000-0002-8827-254X  |1 https://orcid.org/0000-0002-8827-254X  |4 edt  |4 http://id.loc.gov/vocabulary/relators/edt 
710 2 |a SpringerLink (Online service) 
773 0 |t Springer Nature eBook 
776 0 8 |i Printed edition:  |z 9783031631177 
776 0 8 |i Printed edition:  |z 9783031631191 
776 0 8 |i Printed edition:  |z 9783031631207 
830 0 |a Current Topics in Microbiology and Immunology,  |x 2196-9965 ;  |v 445 
856 4 0 |u https://doi.org/10.1007/978-3-031-63118-4 
912 |a ZDB-2-SBL 
912 |a ZDB-2-SXB 
950 |a Biomedical and Life Sciences (SpringerNature-11642) 
950 |a Biomedical and Life Sciences (R0) (SpringerNature-43708)